Form 4: 2seventy bio CEO William D. Baird III Sells Shares to Cover Tax Obligations
SEC Form 4
William D. Baird III, President and CEO of 2seventy bio, Inc., sold shares of common stock to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On January 3, 2025, William D. Baird III, the President and CEO of 2seventy bio, Inc., sold 31,718 shares of common stock at a weighted average price of $2.9359.
- The shares were sold to cover tax withholding obligations incurred in connection with the vesting of restricted stock units.
- Following this transaction, Baird directly owns 862,889 shares of 2seventy bio, Inc.
- On January 6, 2025, Baird sold 763 shares of common stock at a weighted average price of $2.7785.
- Following this transaction, Baird directly owns 862,126 shares of 2seventy bio, Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, reflecting routine stock sales for tax purposes. It doesn't inherently convey positive or negative sentiment.
Industry Context
This is a routine Form 4 filing, indicating insider transactions. It is common for executives to sell shares to cover tax obligations related to vesting equity.
Stakeholder Impact
- The stock sale by the CEO could have a minor, temporary impact on the stock price, but is unlikely to have a significant long-term effect.
Key Dates
| Date | Description |
|---|---|
| 01/03/2025 | William D. Baird III sold 31,718 shares of common stock. |
| 01/06/2025 | William D. Baird III sold 763 shares of common stock. |
| 01/07/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.